| Year |
Citation |
Score |
| 2024 |
van Hooijdonk CFM, Balvers MGJ, van der Pluijm M, Smith CLC, de Haan L, Schrantee A, Yaqub M, Witkamp RF, van de Giessen E, van Amelsvoort TAMJ, Booij J, Selten JP. Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals. Psychological Medicine. 1-11. PMID 38389452 DOI: 10.1017/S0033291724000291 |
0.462 |
|
| 2024 |
van der Pluijm M, Alting M, Schrantee A, Edden RAE, Booij J, de Haan L, van de Giessen E. Glutamate and GABA levels in the anterior cingulate cortex in treatment resistant first episode psychosis patients. Schizophrenia Research. 264: 471-478. PMID 38277736 DOI: 10.1016/j.schres.2024.01.025 |
0.381 |
|
| 2024 |
Belov V, Erwin-Grabner T, Aghajani M, Aleman A, Amod AR, Basgoze Z, Benedetti F, Besteher B, Bülow R, Ching CRK, Connolly CG, Cullen K, Davey CG, Dima D, Dols A, ... ... Schrantee A, et al. Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures. Scientific Reports. 14: 1084. PMID 38212349 DOI: 10.1038/s41598-023-47934-8 |
0.528 |
|
| 2023 |
Boucherie DE, Reneman L, Booij J, Martins D, Dipasquale O, Schrantee A. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study. Journal of Psychopharmacology (Oxford, England). 2698811231211154. PMID 37947344 DOI: 10.1177/02698811231211154 |
0.629 |
|
| 2023 |
Boucherie DE, Reneman L, Ruhé HG, Schrantee A. Neurometabolite changes in response to antidepressant medication: A systematic review of H-MRS findings. Neuroimage. Clinical. 40: 103517. PMID 37812859 DOI: 10.1016/j.nicl.2023.103517 |
0.558 |
|
| 2023 |
Breedt LC, Santos FAN, Hillebrand A, Reneman L, van Rootselaar AF, Schoonheim MM, Stam CJ, Ticheler A, Tijms BM, Veltman DJ, Vriend C, Wagenmakers MJ, van Wingen GA, Geurts JJG, Schrantee A, et al. Multimodal multilayer network centrality relates to executive functioning. Network Neuroscience (Cambridge, Mass.). 7: 299-321. PMID 37339322 DOI: 10.1162/netn_a_00284 |
0.491 |
|
| 2023 |
van Galen KA, Schrantee A, Ter Horst KW, la Fleur SE, Booij J, Constable RT, Schwartz GJ, DiLeone RJ, Serlie MJ. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study. Nature Metabolism. PMID 37308722 DOI: 10.1038/s42255-023-00816-9 |
0.409 |
|
| 2022 |
van Genderen JG, Chia C, Van den Hof M, Mutsaerts HJMM, Reneman L, Pajkrt D, Schrantee A. Brain Differences in Adolescents Living With Perinatally Acquired HIV Compared to Adoption Status Match Controls: A Cross-Sectional Study. Neurology. PMID 35940898 DOI: 10.1212/WNL.0000000000200946 |
0.538 |
|
| 2022 |
Kaiser A, Broeder C, Cohen JR, Douw L, Reneman L, Schrantee A. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD. Human Brain Mapping. PMID 35781371 DOI: 10.1002/hbm.25981 |
0.827 |
|
| 2022 |
Kaiser A, Reneman L, Solleveld MM, Coolen BF, Scherder EJA, Knutsson L, Bjørnerud A, van Osch MJP, Wijnen JP, Lucassen PJ, Schrantee A. A Randomized Controlled Trial on the Effects of a 12-Week High- vs. Low-Intensity Exercise Intervention on Hippocampal Structure and Function in Healthy, Young Adults. Frontiers in Psychiatry. 12: 780095. PMID 35126199 DOI: 10.3389/fpsyt.2021.780095 |
0.77 |
|
| 2021 |
Schalbroeck R, de Geus-Oei LF, Selten JP, Yaqub M, Schrantee A, van Amelsvoort T, Booij J, van Velden FHP. Cerebral [F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits. Diagnostics (Basel, Switzerland). 11. PMID 34943640 DOI: 10.3390/diagnostics11122404 |
0.472 |
|
| 2021 |
Kaiser A, Reneman L, Lucassen PJ, de Vries TJ, Schrantee A, Kaag AM. Targeting working memory to modify emotional reactivity in adult attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Brain Imaging and Behavior. PMID 34524649 DOI: 10.1007/s11682-021-00532-6 |
0.79 |
|
| 2021 |
van Galen KA, Booij J, Schrantee A, Adriaanse SM, Unmehopa UA, Fliers E, Schwartz GJ, DiLeone RJ, Ter Horst KW, la Fleur SE, Serlie MJ. The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity. Metabolism: Clinical and Experimental. 154839. PMID 34331964 DOI: 10.1016/j.metabol.2021.154839 |
0.403 |
|
| 2021 |
Campos AI, Thompson PM, Veltman DJ, Pozzi E, van Veltzen LS, Jahanshad N, Adams MJ, Baune BT, Berger K, Brosch K, Bülow R, Connolly CG, Dannlowski U, Davey CG, de Zubicaray GI, ... ... Schrantee A, et al. Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts. Biological Psychiatry. PMID 34172278 DOI: 10.1016/j.biopsych.2021.03.015 |
0.498 |
|
| 2021 |
Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, ... ... Schrantee A, et al. Correction: Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders. Molecular Psychiatry. PMID 34158622 DOI: 10.1038/s41380-021-01191-1 |
0.531 |
|
| 2021 |
Reneman L, van der Pluijm M, Schrantee A, van de Giessen E. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. European Journal of Radiology. 140: 109752. PMID 34004428 DOI: 10.1016/j.ejrad.2021.109752 |
0.558 |
|
| 2021 |
Hilberdink CE, van Zuiden M, Schrantee A, Korosi A, Kaiser A, Zhutovsky P, Ginty AT, Ensink JBM, Lindauer RJL, Vrijkotte TGM, de Rooij SR. Dysregulated functional brain connectivity in response to acute social-evaluative stress in adolescents with PTSD symptoms. European Journal of Psychotraumatology. 12: 1880727. PMID 33968316 DOI: 10.1080/20008198.2021.1880727 |
0.725 |
|
| 2021 |
Tahmasian M, Aleman A, Andreassen OA, Arab Z, Baillet M, Benedetti F, Bresser T, Bright J, Chee MWL, Chylinski D, Cheng W, Deantoni M, Dresler M, Eickhoff SB, Eickhoff CR, ... ... Schrantee A, et al. ENIGMA-Sleep: Challenges, opportunities, and the road map. Journal of Sleep Research. e13347. PMID 33913199 DOI: 10.1111/jsr.13347 |
0.475 |
|
| 2021 |
Postema MC, Hoogman M, Ambrosino S, Asherson P, Banaschewski T, Bandeira CE, Baranov A, Bau CHD, Baumeister S, Baur-Streubel R, Bellgrove MA, Biederman J, Bralten J, Brandeis D, Brem S, ... ... Schrantee A, et al. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 33748971 DOI: 10.1111/jcpp.13396 |
0.609 |
|
| 2021 |
Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 46: 1-13. PMID 33735707 DOI: 10.1016/j.euroneuro.2021.02.002 |
0.802 |
|
| 2021 |
Van den Hof M, Jellema PEJ, Haar AMT, Scherpbier HJ, Schrantee A, Kaiser A, Caan MWA, Majoie CBLM, Reiss P, Wit FWNM, Mutsaerts HMM, Pajkrt D. Normal structural brain development in adolescents treated for perinatally acquired HIV: A longitudinal imaging study. Aids (London, England). PMID 33710018 DOI: 10.1097/QAD.0000000000002873 |
0.739 |
|
| 2020 |
Arnts H, van Erp WS, Boon LI, Bosman CA, Admiraal MM, Schrantee A, Pennartz CMA, Schuurman R, Stam CJ, van Rootselaar AF, Hillebrand A, van den Munckhof P. Awakening after a sleeping pill: Restoring functional brain networks after severe brain injury. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 132: 135-146. PMID 32979847 DOI: 10.1016/J.Cortex.2020.08.011 |
0.304 |
|
| 2020 |
Hartstra AV, Schüppel V, Imangaliyev S, Schrantee A, Prodan A, Collard D, Levin E, Dallinga-Thie G, Ackermans MT, Winkelmeijer M, Havik SR, Metwaly A, Lagkouvardos I, Nier A, Bergheim I, et al. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Molecular Metabolism. 101076. PMID 32916306 DOI: 10.1016/J.Molmet.2020.101076 |
0.474 |
|
| 2020 |
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, ... ... Schrantee A, et al. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. Jama Psychiatry. PMID 32857118 DOI: 10.1001/Jamapsychiatry.2020.2694 |
0.529 |
|
| 2020 |
Solleveld MM, Schrantee A, Homberg JR, Lucassen PJ, Reneman L. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study. Psychiatry Research. Neuroimaging. 303: 111126. PMID 32592855 DOI: 10.1016/J.Pscychresns.2020.111126 |
0.627 |
|
| 2020 |
Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, Abe Y, Alonso P, Ameis SH, Anikin A, Anticevic A, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, ... ... Schrantee A, et al. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. The American Journal of Psychiatry. appiajp202019030331. PMID 32539527 DOI: 10.1176/Appi.Ajp.2020.19030331 |
0.628 |
|
| 2020 |
Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, ... ... Schrantee A, et al. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 117031. PMID 32526385 DOI: 10.1016/J.Neuroimage.2020.117031 |
0.557 |
|
| 2020 |
Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy-Duchesne B, ... ... Schrantee A, et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Translational Psychiatry. 10: 172. PMID 32472038 DOI: 10.1038/S41398-020-0842-6 |
0.548 |
|
| 2020 |
Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, ... ... Schrantee A, et al. Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders : Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Molecular Psychiatry. PMID 32467648 DOI: 10.1038/S41380-020-0774-9 |
0.57 |
|
| 2020 |
Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, Aftanas L, Aghajani M, Aleman A, Baune BT, Berger K, Brak I, Filho GB, Carballedo A, Connolly CG, Couvy-Duchesne B, ... ... Schrantee A, et al. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Molecular Psychiatry. PMID 32424236 DOI: 10.1038/S41380-020-0754-0 |
0.613 |
|
| 2020 |
Walhovd KB, Amlien I, Schrantee A, Rohani DA, Groote I, Bjørnerud A, Fjell AM, Reneman L. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Ajnr. American Journal of Neuroradiology. 41: 758-765. PMID 32414901 DOI: 10.3174/Ajnr.A6560 |
0.668 |
|
| 2020 |
Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Frontiers in Psychiatry. 11: 82. PMID 32184743 DOI: 10.3389/Fpsyt.2020.00082 |
0.779 |
|
| 2020 |
Schrantee A, Ruhé HG, Reneman L. Psychoradiological Biomarkers for Psychopharmaceutical Effects. Neuroimaging Clinics of North America. 30: 53-63. PMID 31759572 DOI: 10.1016/J.Nic.2019.09.006 |
0.555 |
|
| 2020 |
Schrantee A, Kaiser A, Lindauer R, Bottelier M, Reneman L. The Association Between Medication, Dopamine Function, and Long-Term Symptom Severity in the Matured and Developing Brain in ADHD Biological Psychiatry. 87: S18-S19. DOI: 10.1016/J.Biopsych.2020.02.073 |
0.79 |
|
| 2019 |
Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology. 182528. PMID 31407970 DOI: 10.1148/Radiol.2019182528 |
0.823 |
|
| 2019 |
de Kovel CGF, Aftanas L, Aleman A, Alexander-Bloch AF, Baune BT, Brack I, Bülow R, Busatto Filho G, Carballedo A, Connolly CG, Cullen KR, Dannlowski U, Davey CG, Dima D, Dohm K, ... ... Schrantee A, et al. No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. The American Journal of Psychiatry. appiajp201918101144. PMID 31352813 DOI: 10.1176/Appi.Ajp.2019.18101144 |
0.599 |
|
| 2019 |
Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. Influence of muscarinic M receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Research. Neuroimaging. 290: 5-13. PMID 31252222 DOI: 10.1016/J.Pscychresns.2019.06.005 |
0.671 |
|
| 2019 |
Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, ... ... Schrantee A, et al. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. The American Journal of Psychiatry. appiajp201918091033. PMID 31014101 DOI: 10.1176/Appi.Ajp.2019.18091033 |
0.655 |
|
| 2019 |
Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. Journal of Psychopharmacology (Oxford, England). 269881119836229. PMID 30887865 DOI: 10.1177/0269881119836229 |
0.645 |
|
| 2019 |
Kaiser A, Reneman L, Lucassen P, De Vries T, Kaag A, Schrantee A. P.3.07 Targeting emotional dysregulation in adult attention-deficit hyperactivity disorder European Neuropsychopharmacology. 29: S683-S684. DOI: 10.1016/J.Euroneuro.2019.01.069 |
0.792 |
|
| 2018 |
Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30082141 DOI: 10.1016/J.Euroneuro.2018.07.099 |
0.671 |
|
| 2018 |
Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage. Clinical. 17: 53-59. PMID 29527472 DOI: 10.1016/J.Nicl.2017.09.026 |
0.807 |
|
| 2018 |
Schrantee A, Wijnen JP, Solleveld MM, Nederveen AJ, Dumoulin S, Klomp DW, Reneman L, Lucassen PJ. F153. The Effect of a 12-Week Aerobic Exercise Intervention on Neurometabolites in Young Healthy Adults Using 7T Magnetic Resonance Spectroscopy Biological Psychiatry. 83: S297-S298. DOI: 10.1016/J.Biopsych.2018.02.767 |
0.545 |
|
| 2018 |
Schrantee A, Lucassen PJ, Reneman L, Booij J. T138. Serotonin Transporter Occupancy Predicts Default-Mode Network Connectivity: A SPECT and Resting-State fMRI Study Biological Psychiatry. 83: S182. DOI: 10.1016/J.Biopsych.2018.02.475 |
0.616 |
|
| 2017 |
Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research. 269: 36-42. PMID 28938219 DOI: 10.1016/J.Pscychresns.2017.09.009 |
0.806 |
|
| 2017 |
Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage. Clinical. 15: 812-818. PMID 28725548 DOI: 10.1016/J.Nicl.2017.06.003 |
0.649 |
|
| 2017 |
Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28679529 DOI: 10.1096/Fj.201601234R |
0.631 |
|
| 2017 |
Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? Journal of Cardiovascular Electrophysiology. PMID 28452189 DOI: 10.1111/Jce.13235 |
0.654 |
|
| 2017 |
Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJ, Rombouts SA, Reneman L. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging and Behavior. PMID 28321605 DOI: 10.1007/S11682-017-9707-X |
0.814 |
|
| 2017 |
Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, et al. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. Plos One. 12: e0172776. PMID 28241065 DOI: 10.1371/Journal.Pone.0172776 |
0.687 |
|
| 2017 |
Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage. Clinical. 13: 123-129. PMID 27942455 DOI: 10.1016/J.Nicl.2016.11.021 |
0.819 |
|
| 2017 |
Solleveld M, Schrantee A, Baek H, Bottelier M, Lucassen P, Van Someren E, Rijsman R, Reneman L. Enduring effects of methylphenidate on sleep in children with attention-deficit/hyperactivity disorder: a double-blind randomized controlled trial European Neuropsychopharmacology. 27: S1111-S1112. DOI: 10.1016/S0924-977X(17)31927-2 |
0.615 |
|
| 2017 |
Kaiser A, Schrantee A, Solleveld M, Reneman L, Lucassen P. Effects of cardiovascular fitness on hippocampal volume and vasculature in young adults European Neuropsychopharmacology. 27: S720-S721. DOI: 10.1016/S0924-977X(17)31327-5 |
0.759 |
|
| 2017 |
Schrantee A, Lucassen P, Booij J, Reneman L. Non-invasive magnetic resonance imaging of human serotonin function: dose-dependent effects of citalopram European Neuropsychopharmacology. 27: S707-S708. DOI: 10.1016/S0924-977X(17)31308-1 |
0.645 |
|
| 2016 |
Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HM, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, et al. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27487479 DOI: 10.1001/Jamapsychiatry.2016.1572 |
0.816 |
|
| 2016 |
Bottelier MA, Schrantee A, van Wingen G, Ruhé HG, de Ruiter MB, Reneman L. A power analysis for future clinical trials on the potential adverse effects of SSRIs on amygdala reactivity Frontiers in Biology. 11: 256-259. DOI: 10.1007/S11515-016-1402-6 |
0.59 |
|
| 2015 |
Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging and Behavior. PMID 26149196 DOI: 10.1007/S11682-015-9419-Z |
0.679 |
|
| 2015 |
Schrantee A, Václav? L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1172-80. PMID 25394786 DOI: 10.1038/Npp.2014.301 |
0.691 |
|
| 2015 |
Schrantee A, Mutsaerts H, Tamminga G, Bouziane C, Bottelier M, Rombouts S, Reneman L. P.1.i.044 The effects of methylphenidate on striatal dopamine system are dependent on age: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 25: S326-S327. DOI: 10.1016/S0924-977X(15)30403-X |
0.775 |
|
| 2015 |
Solleveld M, Schrantee A, Bouziane C, Ruhé H, Reneman L. P.1.i.043 Age-dependent effects of selective serotonin reuptake inhibitor exposure on the development of the GABA-ergic system European Neuropsychopharmacology. 25: S325-S326. DOI: 10.1016/S0924-977X(15)30402-8 |
0.755 |
|
| 2015 |
Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9419-z |
0.603 |
|
| 2014 |
Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. Bmc Psychiatry. 14: 48. PMID 24552282 DOI: 10.1186/1471-244X-14-48 |
0.756 |
|
| 2014 |
Schrantee A, Reneman L. Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity. Neuropharmacology. 84: 159-69. PMID 23851258 DOI: 10.1016/J.Neuropharm.2013.06.029 |
0.599 |
|
| 2014 |
Ferguson B, Schrantee A, De Ruiter M, Bottelier M, Reneman L. P.7.e.001 Opposite effects of acute methylphenidate administration in children versus adult ADHD patients during emotional processing European Neuropsychopharmacology. 24: S728-S729. DOI: 10.1016/S0924-977X(14)71173-3 |
0.572 |
|
| 2014 |
Schrantee A, Ferguson B, Stoffers D, Reneman L. P.1.i.028 Effects of dexamphetamine on fronto–striatal network connectivity in recreational users European Neuropsychopharmacology. 24: S313-S314. DOI: 10.1016/S0924-977X(14)70497-3 |
0.517 |
|
| 2013 |
Schrantee A, Tremoleda J, Wylezinska-Arridge M, Gsell W, Reneman L. P.1.i.016 Amphetamine pretreatment alters the response to a methylphenidate challenge: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 23: S272. DOI: 10.1016/S0924-977X(13)70424-3 |
0.56 |
|
| 2012 |
Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. Journal of Visualized Experiments : Jove. PMID 22565099 DOI: 10.3791/3956 |
0.755 |
|
| Show low-probability matches. |